Genomik Design Pharmaceuticals Private Limited
About Genomik Design Pharmaceuticals Private Limited
Data last updated:
Genomik Design Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 07 January 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PTC040246. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Venkata Reddy Massireddigari and Enkemi Reddy Mutyala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.177 Ida Mallapur, Hyderabad, Telangana, India – 500076.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Genomik Design Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2003PTC040246. The current CIN is U24239TG2003PTC040246, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2003PTC040246 | Current |
| U24239AP2003PTC040246 | Previous |
Contact details
Genomik Design Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.177 Ida Mallapur, Hyderabad, Telangana, India – 500076
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Genomik Design Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Genomik Design Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Genomik Design Pharmaceuticals Private Limited, buy the company report.
Board of directors of Genomik Design Pharmaceuticals Private Limited
Genomik Design Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Reddy Massireddigari | Director | 02 Jun 2004 | 22 Years 4 Months | Current |
| Enkemi Reddy Mutyala Also directs: Rational Labs Private Limited | Director | 27 Jun 2011 | 15 Years 4 Months | Current |
| Venkata Reddy Boilla Also directs: Rational Labs Private Limited | Director | 27 Jun 2011 | 15 Years 4 Months | Current |
Auditor
Genomik Design Pharmaceuticals Private Limited is audited by NANDYALA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NANDYALA & ASSOCIATES | FY 2017 | 200900 |
Shareholding
The shareholding of Genomik Design Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Genomik Design Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Genomik Design Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genomik Design Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Genomik Design Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Genomik Design Pharmaceuticals Private Limited, buy the company report.
Recent activity
Genomik Design Pharmaceuticals Private Limited has 5 board changes on record since 2004: 3 appointments and 2 cessations. The latest: Krishna Swaroop Reddy Kasi Reddy ceased to be Director on 01 Mar 2019.
Frequently asked questions
Genomik Design Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in chemical products, within the chemicals industry. It was incorporated on 07 January 2003 (23+ years old) and is registered under CIN U24239TG2003PTC040246.
Genomik Design Pharmaceuticals has 3 current directors:
- Venkata Reddy Massireddigari - Director
- Enkemi Reddy Mutyala - Director
- Venkata Reddy Boilla - Director
The latest financial statements of Genomik Design Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Genomik Design Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Genomik Design Pharmaceuticals is U24239TG2003PTC040246. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genomik Design Pharmaceuticals was incorporated on 07 January 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.
Krishna Swaroop Reddy Kasi Reddy ceased to be Director on 01 Mar 2019. Munagala Chandra Shakar Reddy ceased to be Director on 24 Dec 2015. Enkemi Reddy Mutyala was appointed as Director on 27 Jun 2011. Genomik Design Pharmaceuticals has 5 board changes on record in total.
The registered office of Genomik Design Pharmaceuticals is at Plot No.177 Ida Mallapur, Hyderabad, Telangana, India – 500076.
Genomik Design Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Genomik Design Pharmaceuticals is compliant as of 14 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
